InvestorsHub Logo

MightyX

07/19/19 7:07 AM

#91597 RE: jesler #91596

Yes and only savvy investors would know to read prior filing LMAO, status quo also is only understood by savvy investors LMAO.

MightyX

07/19/19 7:12 AM

#91598 RE: jesler #91596

And isn’t it interesting how Slimpen hasn’t mentioned MYDX yet? Their disposable pens formulated by MYDX 360 data will be a huge hit in 9 days. Watch their countdown at slimpen.com LAUNCH coming. The seller needs to get out, hence the silence by MYDX, then we LAUNCH.

MightyX

07/19/19 7:15 AM

#91599 RE: jesler #91596

Personally, I believe CTO was necessary to keep all partnered/entities legally bound to maintain MYDX anonymity through this process of getting the seller out cheap. I think we could see medical device designation as well for CannaDX and ECOSmartPen.

The CTO specifically explains why not much can be found publicly anymore. Mostly some videos from last proving ECOSmartPena exist.

MightyX

07/19/19 7:20 AM

#91600 RE: jesler #91596

Here’s this article from June 2019 reflecting on the UF/MYDX study...interesting how MYDX isn’t mention...well interesting not because MYDX has never been mentioned but interesting how AFTER the CTO, MYDX isn’t mentioned, MYDX has been mentioned BEFORE CTO...interesting indeed.

https://www.83degreesmedia.com/features/medical-marijuana-conundrum-remains-in-Florida-061819.aspx

We’re GOLDEN. MYDX says when.

VerifyandTrust

07/19/19 9:30 AM

#91608 RE: jesler #91596

CTOs are specific to exhibits and agreements being redacted, yet still must be included in SEC filings. Hence the CTO filed ny SCAMydx stated the 2 specific exhibts impacted. Not the partnership generalizations being tossed around and icorrectly advertised by others.